ACIP Unveils Its 2024 Adult Immunization Recommendations — Schedule must be more user-friendly to improve vaccine uptake, critics say by Katherine Kahn , Staff Writer, MedPage Today January 11, 2024 ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine guidance ...

While ACIP's recommendation of a vaccine has typically been a requirement for payor coverage, Berger said that it is likely other health organizations will need to come out with their own guidelines.

In its final meeting of 2021, ACIP met to review and make recommendations for vaccinations including that of Pfizer’s COVID-19 vaccine for children ages 5-11 as well as for a hepatitis B vaccine ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

The Advisory Committee on Immunization Practices has issued an update to their interim recommendations regarding the use of mRNA vaccines authorized for the prevention of COVID-19.

ACIP consists of 15 experts who are voting members primarily responsible for the vaccine recommendations. The secretary of the U.S. Department of Health and Human Services selects the committee ...

The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months ...

Vaccine advisers to the US Centers for Disease Control and Prevention will meet Thursday to make recommendations on how to address new safety issues concerning the Johnson & Johnson Covid-19 ...

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...